data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Edesa Biotech
(NASDAQ:EDSA)
$1.60
-0.01[-0.62%]
At close: Jul 1
$1.52
-0.0800[-5.00%]
After Hours: 7:05PM EDT
Day High/Low1.51 - 1.63
52 Week High/Low1.3 - 12
Open / Close1.58 / 1.6
Float / Outstanding10M / 15.5M
Vol / Avg.47.1K / 59.7K
Mkt Cap24.7M
P/E-
50d Avg. Price1.9
Div / Yield-
Payout Ratio-
EPS-0.33
Total Float10M

Edesa Biotech (NASDAQ:EDSA), Quotes and News Summary

Edesa Biotech (NASDAQ: EDSA)

Day High/Low1.51 - 1.63
52 Week High/Low1.3 - 12
Open / Close1.58 / 1.6
Float / Outstanding10M / 15.5M
Vol / Avg.47.1K / 59.7K
Mkt Cap24.7M
P/E-
50d Avg. Price1.9
Div / Yield-
Payout Ratio-
EPS-0.33
Total Float10M
Benzinga - May 24, 2022, 1:04PM
Benzinga - May 24, 2022, 10:41AM
Benzinga - May 19, 2022, 2:04PM
Benzinga - May 13, 2022, 8:56AM
Benzinga - Apr 28, 2022, 7:47AM
Benzinga - Mar 22, 2022, 8:35AM
Benzinga - Mar 22, 2022, 8:15AM
Benzinga - Feb 18, 2022, 12:05PM
Benzinga - Feb 17, 2022, 8:02AM
Benzinga - Feb 14, 2022, 9:10AM
Benzinga - Jan 13, 2022, 9:55AM
Benzinga - Jan 13, 2022, 8:03AM
Benzinga - Jan 6, 2022, 10:28AM
Benzinga - Jan 6, 2022, 10:07AM
Benzinga - Dec 28, 2021, 4:25PM
Benzinga - Dec 20, 2021, 6:10AM
Benzinga - Dec 1, 2021, 8:07AM
Benzinga - Nov 4, 2021, 8:12AM
Benzinga - Oct 21, 2021, 2:16PM
Benzinga - Oct 21, 2021, 2:08PM
load more
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-12
REV
Q2 2022Est.ActualSurprise
EPS-0.330
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Edesa Biotech Questions & Answers

Q
How do I buy Edesa Biotech (EDSA) stock?
A

You can purchase shares of Edesa Biotech (NASDAQ: EDSA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Edesa Biotech's (EDSA) competitors?
A

There are no as such competitors for Edesa Biotech.

Q
What is the target price for Edesa Biotech (EDSA) stock?
A

The latest price target for Edesa Biotech (NASDAQ: EDSA) was reported by HC Wainwright & Co. on Monday, December 20, 2021. The analyst firm set a price target for 16.00 expecting EDSA to rise to within 12 months (a possible 900.00% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Edesa Biotech (EDSA)?
A

The stock price for Edesa Biotech (NASDAQ: EDSA) is $1.6 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Edesa Biotech (EDSA) pay a dividend?
A

There are no upcoming dividends for Edesa Biotech.

Q
When is Edesa Biotech (NASDAQ:EDSA) reporting earnings?
A

Edesa Biotech’s Q3 earnings are confirmed for Friday, August 12, 2022.

Q
Is Edesa Biotech (EDSA) going to split?
A

There is no upcoming split for Edesa Biotech.

Q
What sector and industry does Edesa Biotech (EDSA) operate in?
A

Edesa Biotech is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.